Tokyo, March 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060642) titled 'Feasibility Study of Right Subphrenic Cytology Assessment during Robot-Assisted Surgery for Endometrial Cancer' on March 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - National Hospital Organization (NHO) Shikoku Cancer Center
Condition:
Condition - Endometrial carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to evaluate whether right subphrenic cytology can be safely and reliably performed during robot-assisted surgery for patients with endometrial cancer, and whether specimens of sufficient quality for pathological diagnosis can be obtained
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Right subphrenic cytology will be uniformly added for all cases.
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Female
Key inclusion criteria - 1) Diagnosed with endometrial cancer preoperatively
2) Scheduled to undergo robot-assisted surgery
3) Provided written informed consent to participate in this study
4) Age 18 years or older at the time of consent
Key exclusion criteria - 1) Patients deemed inappropriate for inclusion in this study by the attending physician
2) Patients with uterine sarcoma
3) Patients who have received preoperative chemotherapy
4) Women who are pregnant or may be pregnant
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 02 Day
Anticipated trial start date - 2026 Year 03 Month 01 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068578
Disclaimer: Curated by HT Syndication.
